Nusano
  • Home
  • Company
    • Leadership
    • West Valley City
  • Technology
  • News
  • Careers
  • Contact Us
Select Page
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

by Scott Larrivee | Apr 20, 2023 | News

NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...
Case Study: Radioisotope supply challenges affecting prostate cancer treatment

Case Study: Radioisotope supply challenges affecting prostate cancer treatment

by Scott Larrivee | Jan 30, 2023 | Industry News

Jan. 30, 2023 – Health Imaging reports on a new case study published indicating that radioisotope supply issues are delaying prostate cancer treatments using 177Lu-PSMA-617, commonly known as Pluvicto. The health care news source writes: Following its [2022 FDA]...
Global radioisotope shortage hits patients in Pennsylvania

Global radioisotope shortage hits patients in Pennsylvania

by Scott Larrivee | Nov 11, 2022 | Industry News

Nov. 11, 2022 – Pennsylvania-based WellSpan Health is notifying patients that global medical radioisotope shortages will require patients to delay, reschedule, or pursue other imaging solutions. On its website, the health system writes: A critical world-wide shortage...
Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals

Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals

by Scott Larrivee | Nov 10, 2022 | Industry News

Nov. 10, 2022 – The unexpected shut down of a nuclear reactor in Belgium is creating issues for patients in Canada needing medical imaging procedures. The Toronto Star reports: QEII  [Queen Elizabeth II] hospital performs some 6,000 of those diagnostic imaging tests...
University of Missouri responds to global radioisotope shortage

University of Missouri responds to global radioisotope shortage

by Scott Larrivee | Feb 12, 2022 | Industry News

Feb. 12, 2022 – The failure of a nuclear reactor to come back online in the Netherlands is posing medical radioisotope shortages worldwide. In response, the University of Missouri Research Reactor (MURR) is attempting to help alleviate supply chain challenges. Imaging...
« Older Entries

Recent Posts

  • Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
  • Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
  • Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day
  • Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals
  • Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Recent Comments

No comments to show.
Supplying the fight against cancer.
  • Follow
Company
about us
Leadership
Contact us
technology
Proprietary tech
Applications
Investors
Resources
News
Careers
Suppliers
© 2023 Nusano | Web design
Privacy Policy – Terms of Service